IKPM logo

Ikapharmindo Putramas IDX:IKPM Stock Report

Last Price

Rp240.00

Market Cap

Rp404.3b

7D

0%

1Y

-2.4%

Updated

10 May, 2025

Data

Company Financials

PT Ikapharmindo Putramas Tbk

IDX:IKPM Stock Report

Market Cap: Rp404.3b

IKPM Stock Overview

Engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. More details

IKPM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends1/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

PT Ikapharmindo Putramas Tbk Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ikapharmindo Putramas
Historical stock prices
Current Share PriceRp240.00
52 Week HighRp308.00
52 Week LowRp195.00
Beta0
1 Month Change12.15%
3 Month Change-0.83%
1 Year Change-2.44%
3 Year Changen/a
5 Year Changen/a
Change since IPO32.60%

Recent News & Updates

Recent updates

Shareholder Returns

IKPMID Personal ProductsID Market
7D0%-0.8%0.2%
1Y-2.4%-21.6%-2.9%

Return vs Industry: IKPM exceeded the ID Personal Products industry which returned -22.1% over the past year.

Return vs Market: IKPM matched the ID Market which returned -2.9% over the past year.

Price Volatility

Is IKPM's price volatile compared to industry and market?
IKPM volatility
IKPM Average Weekly Movement4.2%
Personal Products Industry Average Movement5.9%
Market Average Movement7.3%
10% most volatile stocks in ID Market14.5%
10% least volatile stocks in ID Market3.5%

Stable Share Price: IKPM has not had significant price volatility in the past 3 months compared to the ID market.

Volatility Over Time: IKPM's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19781,046. Kartonowww.ikapharmindo.com

PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and nutraceuticals; and over-the-counter drugs.

PT Ikapharmindo Putramas Tbk Fundamentals Summary

How do Ikapharmindo Putramas's earnings and revenue compare to its market cap?
IKPM fundamental statistics
Market capRp404.32b
Earnings (TTM)Rp671.49m
Revenue (TTM)Rp405.03b

602.1x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IKPM income statement (TTM)
RevenueRp405.03b
Cost of RevenueRp227.52b
Gross ProfitRp177.51b
Other ExpensesRp176.84b
EarningsRp671.49m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.40
Gross Margin43.83%
Net Profit Margin0.17%
Debt/Equity Ratio69.8%

How did IKPM perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

22%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/10 06:30
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Ikapharmindo Putramas Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.